Toyama, Japan

Isao Adachi

This inventor holds 1 USPTO granted patent. Top assignee: The University of Toyama. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Isao Adachi. Retrieved from https://idiyas.com/inventor/isao-adachi-8cdtzln9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Isao Adachi: Innovator in Pharmaceutical Chemistry

Introduction

Isao Adachi is a notable inventor based in Toyama, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative research and development of compounds with therapeutic potential.

Latest Patents

Adachi holds a patent for a "Fused tricyclic compound having aldose reductase inhibitory activity." This compound is characterized by a complex structure that includes various substituents, such as hydrogen atoms, halogens, and alkyl groups. The patent outlines the specific formula and functional groups involved, showcasing the compound's potential in medical applications.

Career Highlights

Isao Adachi is affiliated with the University of Toyama, where he conducts his research. His work focuses on developing compounds that can inhibit aldose reductase, an enzyme linked to various health conditions, including diabetes. His innovative approach has led to advancements in the understanding and treatment of related diseases.

Collaborations

Adachi collaborates with esteemed colleagues, including Naoki Toyooka and Atsushi Kato. Their combined expertise enhances the research efforts at the University of Toyama, fostering an environment of innovation and discovery.

Conclusion

Isao Adachi's contributions to pharmaceutical chemistry through his patented inventions highlight his role as a key innovator in the field. His work continues to pave the way for advancements in medical treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…